Xvivo Perfusion AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0004840718
SEK
178.90
6.5 (3.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Xvivo Perfusion AB stock-summary
stock-summary
Xvivo Perfusion AB
Pharmaceuticals & Biotechnology
Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The Company markets its products in Europe, Asia, Middle East, and North & South America.
Company Coordinates stock-summary
Company Details
Massans gata 10 , GOETEBORG None : 412 51
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Gosta Johannesson
Chairman of the Board
Mr. Dag Andersson
Independent Director
Ms. Yvonne Martensson
Independent Director
Dr. Folke Nilsson
Independent Director
Ms. Camilla Oberg
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
178 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 5,242 Million (Small Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

2.30%

stock-summary
Price to Book

2.50